RRSP Investors: Should You Buy Nutrien Stock Now?

Nutrien stock is enjoying a great run in 2022. Are more gains on the way?

| More on:

Nutrien (TSX:NTR)(NYSE:NTR) stock is up 45% in 2022. Investors who missed the rally are wondering if the Canadian fertilizer giant is still undervalued and deserves to be in a self-directed RRSP portfolio.

Nutrien overview

Nutrien is a relatively new name on the TSX Index, but the company has been around for a long time. Potash Corp and Agrium merged in 2018 to create Nutrien. The marriage made sense given that both companies were based in Canada and already sold their potash production on the global wholesale market together through a joint partnership business called Canpotex.

Management on both sides of the deal completed major capital projects before putting the two companies together. These initiatives have helped Nutrien in the past year by providing spare potash production capacity the company is able to bring online quickly and at low cost.

Agrium contributed a strong retail business to the deal, while Potash Corp was primarily a wholesale provider of fertilizers. Nutrien is a stronger and more balanced company from a revenue perspective than either Potash Corp or Agrium before the merger. Today, Nutrien is the planet’s largest potash producer and a leading supplier of nitrogen and phosphate. Farmers around the globe use the crop nutrients to boost yields.

The retail business continues to expand through strategic acquisitions. Nutrien has the financial firepower to do deals as the sector consolidates and the company leverages its relationships with more than 500,000 farmers who buy its seed and crop protection products. Nutrien has also invested in digital technologies and services to help its clients make their businesses more efficient.

Fertilizer prices

Potash, nitrogen, and phosphate prices go through commodity cycles. The sector was already on the upswing after a multi-year slump when the pandemic hit and drove up crop prices. The surge in margins for farmers has led to an increase in acres being planted to take advantage of strong market conditions.

At the same time, the implementation of sanctions and against Belarus and now Russia have created a drop in global potash supplies. The two countries typically account for 40% of the potash sold around the globe. According to Nutrien’s Q1 2022 report these countries saw their sales dip 20% in the first three months of 2022.

Nutrien increased its potash production by one million tonnes in the second half of 2021 to fill the gap caused by the sanctions placed on Belarus last year and intends to increase output by another one million tonnes in 2022 to meet demand.

Fertilizer prices are expected to remain at elevated levels for some time, and this could be the early innings of a protracted bull market for these commodities.

Should you buy Nutrien stock now?

Nutrien raised the low end of its full-year 2022 adjusted EBITDA guidance from $10 billion to $14.5 billion when it reported Q1 2022 earnings results. This is a material upgrade, and while the market might have had some of it already priced into the stock, the share price still might not fully reflect the revenue and free cash flow potential.

At some point down the road, crop nutrient prices will peak again and tumble before starting a new cycle. That might not happen for quite a while, and Nutrien’s share price has the potential to move significantly higher before that occurs.

The stock currently trades near $133 per share compared to the 2022 high around $148. If you have some cash to put to work in a self-directed RRSP, this stock deserves to be on your radar.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends Nutrien Ltd. Fool contributor Andrew Walker has no position in any stock mentioned.

More on Investing

Canadian Dollars bills
Dividend Stocks

3 Monthly-Paying Dividend Stocks to Boost Your Passive Income

Given their healthy cash flows and high yields, these three monthly-paying dividend stocks could boost your passive income.

Read more »

ways to boost income
Investing

Are Telus and BCE Stocks a Smart Buy for Canadian Investors?

Telus (TSX:T) and BCE (TSX:BCE) have massive dividend yields, but their shares have been quite sluggish!

Read more »

investment research
Tech Stocks

Is OpenText Stock a Buy, Sell, or Hold for 2025?

Is OpenText stock poised for a 2025 comeback? AI ambitions, a 3.8% yield, and cash flow power make it a…

Read more »

Make a choice, path to success, sign
Dividend Stocks

The TFSA Blueprint to Generate $3,695.48 in Yearly Passive Income

The blueprint to generate yearly passive income in a TFSA is to maximize the contribution limits.

Read more »

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Emerging Canadian AI Companies With Big Potential

These tech stocks are paving the way to an AI-filled future, but still offer enough growth ahead for a strong…

Read more »

Young Boy with Jet Pack Dreams of Flying
Tech Stocks

Is Constellation Software Stock a Buy, Sell, or Hold for 2025?

CSU stock has long been a strong option for high growth, high value stocks. But are there now too many…

Read more »

rising arrow with flames
Investing

2 Riskier Stocks With High Potential for Canadian Investors in November

Risky stocks such as Well Health Technologies have the potential to provide life-changing long-term returns.

Read more »

hand stacks coins
Dividend Stocks

3 Ultra-High-Yield Dividend Stocks You Can Buy and Hold for a Decade

These three high-yield dividend stocks still have some work to do, but each are in steady areas that are only…

Read more »